public monies; genetic sequencing; prohibition

Added a prohibition preventing the use of public monies to pay for genetic sequencing procedures performed by devices made by companies domiciled in foreign adversaries.

Defined 'foreign adversary' to include specific countries like China, Russia, and Iran, as well as their agents or entities under significant control.

Defined 'genetic sequencing' as any method to determine the identity and order of nucleotide bases in the human genome.

Corrected contradictory text regarding whether public monies can be spent on premiums, clarifying that funds cannot be used for genetic sequencing from foreign adversaries but can be used for other approved coverage.

Removed repetitive and conflicting clauses about premium payments and coverage limits to create a consistent legal text.